Multiplexed Assays for Improving Rheumatoid Arthritis Diagnostics

Information

• Research Project
• 8833870

• ApplicationId

  8833870

• Core Project Number

  R43AR067113

• Full Project Number

  1R43AR067113-01A1

• Serial Number

  067113

• FOA Number

  PA-12-191

• Sub Project Id

• Project Start Date

  9/18/2014 - 9 years ago

• Project End Date

  8/31/2016 - 7 years ago

• Program Officer Name

  MAO, SU-YAU

• Budget Start Date

  9/18/2014 - 9 years ago

• Budget End Date

  8/31/2016 - 7 years ago

• Fiscal Year

  2014

• Support Year

  01

• Suffix

  A1

• Award Notice Date

  9/17/2014 - 9 years ago

Organizations

• PROGNOSYS BIOSCIENCES, INC.

DESCRIPTION (provided by applicant): There is a need for multiplexed assay technologies that enable diagnostics and detailed characterization of rheumatoid arthritis. In this project we plan to discover new rheumatoid arthritis biomarkers and implement them in a panel of multiplexed assays. We propose a novel approach that offers significant advances over existing methods, including the ability to rapidly develop, validate, and implement highly multiplexed, high- performance assays. If successful, our long-term goal is to transfer these new assays to the clinic as valuable new tools for high sensitivity diagnostics and treatment decision- making.

IC Name

• Activity

  R43

• Administering IC

  AR

• Application Type

  1

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  224688

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  846

• Ed Inst. Type

• Funding ICs

  NIAMS:224688\

• Funding Mechanism

  SBIR-STTR RPGs

• Study Section

  ZRG1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  PROGNOSYS BIOSCIENCES, INC.

• Organization Department

• Organization DUNS

  170943737

• Organization City

  SAN DIEGO

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  921211213

• Organization District

  UNITED STATES